Hainan Huluwa Pharmaceutical Group Co Ltd
Hainan Huluwa Pharmaceutical Group Co., Ltd. research, develops, produces, and sells drugs in the areas of Children's digestive system, respiratory system, anti-infection, anti-virus and other fields in China. The company offers pediatrics, gynecology, antibiotics, respiratory, digestive system, cardiovascular and cerebrovascular, nourishment, and other medicine products. Hainan Huluwa Pharmaceut… Read more
Hainan Huluwa Pharmaceutical Group Co Ltd (605199) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.060x
Based on the latest financial reports, Hainan Huluwa Pharmaceutical Group Co Ltd (605199) has a cash flow conversion efficiency ratio of 0.060x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥44.34 Million) by net assets (CN¥735.65 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Hainan Huluwa Pharmaceutical Group Co Ltd - Cash Flow Conversion Efficiency Trend (2016–2024)
This chart illustrates how Hainan Huluwa Pharmaceutical Group Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Hainan Huluwa Pharmaceutical Group Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Hainan Huluwa Pharmaceutical Group Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Sarawak Oil Palms Bhd
KLSE:5126
|
0.021x |
|
Gaotu Techedu Inc
F:18WA
|
N/A |
|
Golden Flower Tbk PT
JK:POLU
|
0.204x |
|
China Fangda Group Co Ltd
SHE:200055
|
0.006x |
|
LIFE SCI.REIT PLC LS -01
F:JL6
|
N/A |
|
Hefei Snowky Elec Co Ltd
SHE:001387
|
0.024x |
|
Zhejiang Huada New Materials Co Ltd
SHG:605158
|
0.025x |
|
Hung Ching Development & Construction Co Ltd
TW:2527
|
-0.026x |
Annual Cash Flow Conversion Efficiency for Hainan Huluwa Pharmaceutical Group Co Ltd (2016–2024)
The table below shows the annual cash flow conversion efficiency of Hainan Huluwa Pharmaceutical Group Co Ltd from 2016 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥743.28 Million | CN¥-149.12 Million | -0.201x | -923.26% |
| 2023-12-31 | CN¥1.16 Billion | CN¥28.25 Million | 0.024x | -89.64% |
| 2022-12-31 | CN¥1.02 Billion | CN¥238.71 Million | 0.235x | +113.48% |
| 2021-12-31 | CN¥930.52 Million | CN¥102.48 Million | 0.110x | +2958.79% |
| 2020-12-31 | CN¥916.48 Million | CN¥3.30 Million | 0.004x | -98.40% |
| 2019-12-31 | CN¥643.94 Million | CN¥144.51 Million | 0.224x | +326.73% |
| 2018-12-31 | CN¥604.61 Million | CN¥31.80 Million | 0.053x | -79.46% |
| 2017-12-31 | CN¥351.38 Million | CN¥89.96 Million | 0.256x | -49.28% |
| 2016-12-31 | CN¥128.69 Million | CN¥64.96 Million | 0.505x | -- |